Hamps Bio Limited (HAMPS.BO)
BSE · INR · Healthcare · Pharmaceutical Retailers
₹25.50 (+2.00%) as of
Key statistics
- Market cap
- 222.16M
- EPS (TTM)
- -0.85
- Dividend yield
- 0.00%
- 52-week range
- 13.36 – 26.58
- Revenue (TTM)
- 84.75M
- Profit margin
- -8.72%
- Volume
- 4.00k
About Hamps Bio Limited
Hamps Bio Limited engages in marketing and manufacturing of pharmaceutical, freeze-dried food, and nutraceutical ingredients in India and internationally. It operates through Pharma Products and Freeze-Dried Products segments. The company offers nutrition supplements, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ingredients for fruit tea / traditional tea, fruit snacks / juice powder, foods, and super food. The company sells its products under the HAMPS and FzyEzy brands through distribution network and e-commerce platform. Hamps Bio Limited was incorporated in 2007 and is based in Surat, India.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Surat, India
- Employees
- 51
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.